Showing results (791-800 of 1,788) with videos related to
Sort By:
Pageof 179
Pathology, Research and Practice|April 24, 2012
Extra-osseous Ewing sarcoma of the thyroid gland mimicking lymphoma recurrence: a case reportElena Maldi, Guido Monga, Davide Rossi, et al.Recenti Progressi in Medicina|November 1, 1995
Benign recurrent intrahepatic cholestasis. Some reflections on a case followed for 20 yearsP Lovisetto, P Raviolo, L Marchi, et al.Urology|January 25, 2011
Shock wave lithotripsy associated with greater prevalence of hypertensionPhilip V Barbosa, Antoine A Makhlouf, Daniel Thorner, et al.BJU International|July 27, 2016
Accuracy of ultrasonography for renal stone detection and size determination: is it good enough for management decisions?Vishnu Ganesan, Shubha De, Daniel Greene, et al.Journal of Family Medicine and Primary Care|May 21, 2021
Oral manifestations and dental practice recommendations during COVID-19 pandemicGaurav Singh, Harsh Priya, Deepika Mishra, et al.Obstetrics and Gynecology|November 5, 1999
Antenatal prediction of postpartum urinary and fecal incontinenceC Chaliha, V Kalia, S L Stanton, et al.Plos One|January 13, 2017
Co-Occurrence of Asthma and Nephrolithiasis in ChildrenGanesh K Kartha, Ina Li, Suzy Comhair, et al.Oman Medical Journal|February 15, 2021
--Immunophenotypic Aberrancies in Acute Leukemia: A Tertiary Care Centre ExperienceMonika Gupta, Lovekesh Monga, Dimple Mehrotra, et al.European Journal of Medicinal Chemistry|July 26, 2019
An insight into the medicinal perspective of synthetic analogs of indole: A reviewVishali Garg, Rahul Kumar Maurya, Punniyakoti Veeraveedu Thanikachalam, et al.Diabetes|March 25, 2010
Physiologic and pharmacologic modulation of glucose-dependent insulinotropic polypeptide (GIP) receptor expression in beta-cells by peroxisome proliferator-activated receptor (PPAR)-gamma signaling: possible mechanism for the GIP resistance in type 2 diabetesDhananjay Gupta, Mina Peshavaria, Navjot Monga, et al.Pageof 179